Gribbles Pathology Malaysia

What Gribbles Pathology Malaysia does

Innoquest Pathology Sdn. Bhd., formerly Gribbles Pathology Malaysia, is a private multidisciplinary clinical laboratory headquartered in Petaling Jaya, Malaysia, founded in 1996 and rebranded under its current name in May 2022. The company positions itself as the largest private diagnostic laboratory services provider in Malaysia and the only multidisciplinary clinical laboratory in the country holding both College of American Pathology (CAP) and MS ISO 15189 accreditations. Its service portfolio spans a comprehensive test menu covering pathology testing for infections, allergies, chronic diseases, and cancer, supported by an integrated logistics stack that includes courier specimen pickup, on-site screening, phlebotomy, and sample collection. Digital infrastructure consists of an e-Results Portal and a Biomarking consumables storefront hosted on the my.biomarking.com domain, which allow clinicians to access test results and order lab consumables electronically.

The company operates a B2B enterprise field-sales model targeting clinicians, hospitals, and medical centres as its primary customer segments, with patients served indirectly through these providers. Its revenue mechanics are anchored in recurring clinical laboratory diagnostic services billed per test or under service-level arrangements with healthcare institutions, supplemented by consumables sales and continuing medical education (CME) programmes for clinicians. Distribution relies on a direct laboratory footprint, a courier network for specimen collection, mobile phlebotomy teams, and the e-Results Portal for digital result delivery. The firm is privately held, with no disclosed funding rounds, ownership structure, or management team details in the public record, and currently maintains a workforce in the 1,001–5,000 employee range.

Name

Gribbles Pathology Malaysia

Legal name

Innoquest Pathology Sdn. Bhd.

Website

https://gribbles.com.my

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Innoquest Pathology (formerly Gribbles Pathology) is a private multidisciplinary clinical laboratory in Malaysia offering diagnostic testing, e-Results, courier, phlebotomy, and on-site screening services to clinicians, hospitals, and medical centres.

Ownership category

akta.pro rank

Product category

Clinical Diagnostic Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA)

akta.pro secondary industries

Microbiology & Infectious Disease Testing Laboratories (HLAFAMAD), Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics) (HLAHAAAN)

Keywords

• Diagnostic laboratory services
• Pathology testing services
• Medical laboratory diagnostics
• Clinical pathology testing
• Healthcare diagnostic services

Headquarters

HQ city

Petaling Jaya

HQ country

Malaysia

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure

Revenue model

1. Clinical Laboratory Diagnostic Services: Medical laboratory testing services provided to clinicians, hospitals, and medical centres. Services include comprehensive test menus, on-site screening, courier specimen pickup, and phlebotomy services.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Innoquest Pathology (formerly Gribbles Pathology) operates a multidisciplinary clinical laboratory in Malaysia delivering a comprehensive diagnostic test menu covering infections, allergies, chronic diseases, cancer, and other medical conditions. Services are provided to clinicians, hospitals, and medical centres through specimen pickup, phlebotomy, on-site screening, and a digital e-Results portal, with laboratory consumables sold to clinician customers.

Product overview

Innoquest Pathology (formerly Gribbles Pathology) is a single unified multidisciplinary clinical laboratory offering a comprehensive portfolio of diagnostic services. The core offering includes Laboratory Tests with an extensive test menu, supported by On-Site Screening, Courier Services, Phlebotomy Services, and Sample Collection. The company provides a digital e-Results Portal for electronic access to test results, Lab Consumables for clinicians, and Innoquest CME for continuing medical education. All services are delivered under dual accreditation (CAP and MS ISO 15189) with state-of-the-art IT support systems.

Differentiator

Problem solved

Functional benefit

Products and services

• Laboratory Tests Comprehensive diagnostic test menu covering infections, allergies, chronic diseases, cancer, and other medical conditions, delivered under CAP and MS ISO 15189 accreditation for clinicians, hospitals, medical centres, and patients.
• On-Site Screening Mobile health screening services deployed at client locations (corporates, hospitals, medical centres), providing phlebotomy and on-site preventive screening to patients and organizations.
• Courier Services Specimen pickup and delivery services from collection points to the laboratory, enabling seamless testing operations for clinician and hospital customers across Malaysia.
• Phlebotomy Services Blood and specimen collection services provided for laboratory testing, offered to clinicians, hospitals, medical centres, and patients.
• e-Results Portal Online portal that enables clinicians and patients to access diagnostic test results electronically, supporting digital workflow integration for healthcare providers.
• Lab Consumables Laboratory consumables and supplies sold to clinicians via the Biomarking online store for clinical practice use.
• Innoquest CME (Continuing Medical Education) Continuing Medical Education program for healthcare professionals featuring scientific content and updates on new diagnostic tests, supporting clinician engagement and education.

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators1 record

Recent moves1 record

Expansion highlights4 records

Direct peers

• BP Healthcare: Major Malaysian private healthcare group operating diagnostic laboratories alongside clinical services. Directly competes with Innoquest as a large-scale private diagnostic provider with extensive collection centres across Malaysia.
• Quantum Diagnostics: Malaysian diagnostic laboratory offering a wide range of pathology tests to healthcare providers. Direct competitor in the private clinical lab segment with similar B2B motion targeting clinicians and hospitals.
• Pantai Premier Pathology: One of the largest private pathology laboratory networks in Malaysia, operated under Pantai Holdings. Directly competes with Innoquest in providing diagnostic testing services to hospitals, clinicians, and patients across Malaysia with a comparable comprehensive test menu.
• Pathlab Malaysia: Established Malaysian private medical laboratory providing pathology and diagnostic testing services. Competes with Innoquest on test menu breadth, clinician relationships, and turnaround times within the same Malaysian market.

Broad incumbents

• Sonic Healthcare: Global medical diagnostics leader operating pathology laboratories across multiple geographies. Comparable in clinical lab services and operational scale, providing a benchmark for what an institutionalised pathology network looks like at scale.
• Qualitas Medical Group: Larger Malaysian private healthcare provider offering a portfolio including diagnostics, primary care, and occupational health. Overlaps with Innoquest in diagnostic laboratory services as part of a broader healthcare services portfolio.
• KPJ Healthcare (Lab Services): Major Malaysian private hospital group with significant in-house and external laboratory operations. Competes indirectly by capturing diagnostic volumes within its hospital network and may pursue third-party lab partnerships.
• IHH Healthcare (Pathology Division): Large private hospital operator in Malaysia (Gleneagles, Pantai) with significant captive diagnostic lab operations. Represents a major institutional competitor with the scale to invest in lab capabilities and pursue external referrals.

Regional players

• Pathology Asia Holdings: Singapore-headquartered pathology services group with operations across Southeast Asia. Comparable business model in clinical diagnostics and represents a potential regional consolidator or competitor expanding into Malaysia.

Emerging players

• Lab-Link (M) Sdn Bhd: Smaller Malaysian clinical laboratory providing pathology services to healthcare providers. Represents the fragmented long-tail of private labs that Innoquest could potentially acquire or compete against for clinician relationships.

Market position

Strengths1 record

Weaknesses1 record

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/innoquest.diagnostics
• LinkedInlinkedin.com/company/gribbles-pathology-of-malaysia

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Gribbles Pathology Malaysia